Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

Abstract

IMPORTANCE In locally advanced pancreatic cancer, the role of chemoradiotherapy is controversial and the efficacy of erlotinib is unknown. OBJECTIVES To assess whether chemoradiotherapy improves overall survival of patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine-based induction chemotherapy and to assess the… (More)
DOI: 10.1001/jama.2016.4324

Topics

5 Figures and Tables

Cite this paper

@article{Hammel2016EffectOC, title={Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.}, author={P. Chris Hammel and Florence Huguet and Jean-Luc van Laethem and David Goldstein and Bengt Glimelius and Pascal Artru and Ivan Borbath and Olivier Bouch{\'e} and Jenny Shannon and Thierry Andr{\'e} and Laurent Mineur and Benoist Chibaudel and Franck. Bonnetain and Christophe Louvet}, journal={JAMA}, year={2016}, volume={315 17}, pages={1844-53} }